Cargando…
Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?—The IDENTIFY Trial
Therapeutic agents for the novel coronavirus disease 2019 (COVID-19) have been proposed, but evidence supporting their use is limited. A machine learning algorithm was developed in order to identify a subpopulation of COVID-19 patients for whom hydroxychloroquine was associated with improved surviva...
Autores principales: | Burdick, Hoyt, Lam, Carson, Mataraso, Samson, Siefkas, Anna, Braden, Gregory, Dellinger, R. Phillip, McCoy, Andrea, Vincent, Jean-Louis, Green-Saxena, Abigail, Barnes, Gina, Hoffman, Jana, Calvert, Jacob, Pellegrini, Emily, Das, Ritankar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760047/ https://www.ncbi.nlm.nih.gov/pubmed/33256141 http://dx.doi.org/10.3390/jcm9123834 |
Ejemplares similares
-
A Racially Unbiased, Machine Learning Approach to Prediction of Mortality: Algorithm Development Study
por: Allen, Angier, et al.
Publicado: (2020) -
Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trial
por: Burdick, Hoyt, et al.
Publicado: (2020) -
A Machine Learning Approach to Predict Deep Venous Thrombosis Among
Hospitalized Patients
por: Ryan, Logan, et al.
Publicado: (2021) -
Machine Learning as a Precision-Medicine Approach to Prescribing COVID-19 Pharmacotherapy with Remdesivir or Corticosteroids
por: Lam, Carson, et al.
Publicado: (2021) -
Mortality prediction model for the triage of COVID-19, pneumonia, and mechanically ventilated ICU patients: A retrospective study
por: Ryan, Logan, et al.
Publicado: (2020)